Clinical Trial Details
| Trial ID: | L6705 |
| Source ID: | NCT05113693 |
| Associated Drug: | Ckd-393 |
| Title: | Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-393 |
| Acronym: | |
| Status: | COMPLETED |
| Study Results: | NO |
| Results: | |
| Conditions: | Type 2 Diabetes |
| Interventions: | DRUG: CKD-393|DRUG: CKD-501, D759, H053 |
| Outcome Measures: | Primary: AUCt of CKD-501, D759, H053, AUCt: Area under the concentration-time curve from time zero to time, Pre-dose(0 hour), 0.25, 0.5, 0.75, 1, 1.5, 2, 2.5, 3, 4, 6, 8, 12, 24, 48 hour|Cmax of CKD-501, D759, H053, Cmax: Maximum plasma concentration of the drug, Pre-dose(0 hour), 0.25, 0.5, 0.75, 1, 1.5, 2, 2.5, 3, 4, 6, 8, 12, 24, 48 hour | |
| Sponsor/Collaborators: | Sponsor: Chong Kun Dang Pharmaceutical |
| Gender: | ALL |
| Age: | ADULT |
| Phases: | PHASE1 |
| Enrollment: | 33 |
| Study Type: | INTERVENTIONAL |
| Study Designs: | Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: TREATMENT |
| Start Date: | 2021-11-25 |
| Completion Date: | 2021-12-10 |
| Results First Posted: | |
| Last Update Posted: | 2023-06-09 |
| Locations: | Chonbuk National University Hospital, Jeonju, Korea, Republic of |
| URL: | https://clinicaltrials.gov/show/NCT05113693 |
| Drug ID | Drug Name | Type | DrugBank ID | Targets | Category | Latest Progress |
|---|